Man Group
AVNS

Man Group’s Avanos Medical AVNS Stock Holding History

Man Group’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-222,418
Closed -$2.5M – 2387
2025
Q4 		$2.5M Buy
222,418
+148,320
+200% +$1.7M ﹤0.01% 1374
2025
Q3 		$857K Buy
74,098
+31,657
+75% +$371K ﹤0.01% 1722
2025
Q2 		$519K Buy
42,441
+21,143
+99% +$266K ﹤0.01% 1819
2025
Q1 		$305K Buy
+21,298
New +$333K ﹤0.01% 1929
2022
Q2 		– Sell
-10,859
Closed -$364K – 2051
2022
Q1 		$364K Buy
+10,859
New +$350K ﹤0.01% 1688
2021
Q3 		– Sell
-67,703
Closed -$2.46M – 1894
2021
Q2 		$2.46M Buy
67,703
+26,354
+64% +$1.09M 0.01% 1158
2021
Q1 		$1.81M Buy
41,349
+3,658
+10% +$172K 0.01% 1140
2020
Q4 		$1.73M Sell
37,691
-40,389
-52% -$1.68M 0.01% 1253
2020
Q3 		$2.59M Buy
+78,080
New +$2.5M 0.01% 1101
2018
Q4 		– Sell
-19,858
Closed -$1.36M – 1916
2018
Q3 		$1.36M Sell
19,858
-66,168
-77% -$4.26M 0.01% 1546
2018
Q2 		$4.92M Sell
86,026
-25,397
-23% -$1.34M 0.02% 952
2018
Q1 		$5.13M Buy
+111,423
New +$5.29M 0.02% 829

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Man Group's AVNS Position: Q1 2026 in Review

Man Group sold out of Avanos Medical (AVNS) in Q1 2026, closing a stake of 222,418 shares — an estimated $2.5M sold.

Man Group first reported a position in AVNS in Q1 2018 and held it in 12 quarters. The position peaked at $5.13M in Q1 2018. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Man Group reported no remaining Avanos Medical position as of Q1 2026 after selling out during the quarter.
  • Man Group sold 222,418 Avanos Medical shares in Q1 2026, an estimated $2.5M.
  • Man Group first reported a position in Avanos Medical in Q1 2018 and held it in 12 quarters.
  • Man Group's Avanos Medical position peaked at $5.13M in Q1 2018.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.